353 related articles for article (PubMed ID: 18931010)
1. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J
J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371
[TBL] [Abstract][Full Text] [Related]
3. Studies on anti-myelin antibodies in patients with multiple sclerosis.
Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G
Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125
[TBL] [Abstract][Full Text] [Related]
4. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.
Eikelenboom MJ; Petzold A; Lazeron RH; Silber E; Sharief M; Thompson EJ; Barkhof F; Giovannoni G; Polman CH; Uitdehaag BM
Neurology; 2003 Jan; 60(2):219-23. PubMed ID: 12552034
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
8. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
Matà S; Lolli F; Söderström M; Pinto F; Link H
Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
[TBL] [Abstract][Full Text] [Related]
10. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
11. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
Rouwette M; Somers K; Govarts C; De Deyn PP; Hupperts R; Van Wijmeersch B; De Jong BA; Verbeek MM; Van Pesch V; Sindic C; Villar LM; Álvarez-Cermeño JC; Stinissen P; Somers V
J Neurochem; 2012 Nov; 123(4):568-77. PubMed ID: 22958230
[TBL] [Abstract][Full Text] [Related]
12. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
[TBL] [Abstract][Full Text] [Related]
13. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases.
Page N; Perruisseau G; Steck AJ
J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219
[TBL] [Abstract][Full Text] [Related]
14. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
Rawes JA; Calabrese VP; Khan OA; DeVries GH
Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
[TBL] [Abstract][Full Text] [Related]
16. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
Kasai N; Pachner AR; Yu RK
J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
[TBL] [Abstract][Full Text] [Related]
18. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients.
Breij EC; Heijnen P; van der Goes A; Teunissen CE; Polman CH; Dijkstra CD
J Neuroimmunol; 2006 Jul; 176(1-2):106-14. PubMed ID: 16712958
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis.
Ilyas AA; Chen ZW; Cook SD
J Neuroimmunol; 2003 Jun; 139(1-2):76-80. PubMed ID: 12799023
[TBL] [Abstract][Full Text] [Related]
20. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
Jarius S; König FB; Metz I; Ruprecht K; Paul F; Brück W; Wildemann B
J Neuroinflammation; 2017 Aug; 14(1):171. PubMed ID: 28851393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
